Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 28, 2026
Boeing (BA) Q2 2026 Earnings Preview: Delivery Momentum Builds in Recovery Phase

Boeing (BA) Q2 2026 Earnings Preview: Delivery Momentum Builds in Recovery Phase

Key Takeaways

  • Boeing is scheduled to report Q2 2026 results on Tuesday, July 28, before the market opens, with a conference call at 10:30 a.m. ET.
  • Wall Street consensus estimates point to a loss of approximately $0.27 to $0.28 per share, a sharp improvement from the $1.24 loss reported in Q2 2025.
  • Revenue is expected to land near $24.2 billion, up roughly 6% to 7% year over year, supported by 171 commercial aircraft deliveries in the quarter.
  • Commercial deliveries reached 314 units for the first half of 2026 — the strongest first-half performance since 2018 — driven by 129 737 and 25 787 Dreamliner handovers.
  • Options markets are pricing in a post-earnings move of approximately 6%, above Boeing's four-quarter average absolute move of roughly 3.95%.
  • Investors will closely watch free cash flow trends, production rate updates on the 737 program, and any new charges in the Defense, Space & Security segment.

Why This Earnings Report Matters

Boeing's Q2 2026 report arrives at a pivotal moment in the company's multiyear recovery. After years of production disruptions, regulatory scrutiny, and financial losses, the aerospace giant is showing tangible signs of operational improvement under CEO Kelly Ortberg. The first quarter delivered a narrower-than-expected core loss of $0.20 per share on revenue of $22.2 billion, marking a 14% year-over-year top-line gain. Now, with commercial deliveries accelerating to their fastest pace in nearly a decade and a record $695 billion backlog providing exceptional revenue visibility, investors are asking whether Boeing can translate higher output into shrinking losses and eventually positive free cash flow. This report will serve as a critical checkpoint on that path. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

What Analysts Are Expecting

Analysts anticipate Boeing will report an adjusted loss in the range of $0.24 to $0.31 per share for Q2 2026, with consensus clustering around a $0.27 to $0.28 loss. That would represent a roughly 77% to 80% improvement from the $1.24 per-share loss in the same quarter last year. Revenue consensus sits near $24.2 billion, reflecting a mid-single-digit increase from $22.75 billion in Q2 2025.

Delivery data provides a constructive backdrop. Boeing handed over 171 commercial jets in the quarter — including 129 737s and 25 787s — up from 143 in Q1 and 130 in Q1 2025. The Defense, Space & Security segment also delivered 35 aircraft and systems. Historically, Boeing collects the bulk of an aircraft's purchase price at delivery, making the volume ramp a direct input into both revenue and cash flow.

Key metrics beyond the headline numbers include free cash flow (FCF), which came in at negative $1.5 billion in Q1, an improvement from negative $2.3 billion a year earlier. Investors will assess whether higher delivery volume pushed FCF closer to breakeven. Production rate commentary on the 737 program — which is transitioning to 47 jets per month from 42, with Federal Aviation Administration (FAA) concurrence — will also be closely parsed. Additionally, any cost overruns or charges on fixed-price defense contracts remain a persistent wildcard. From what I see, running the numbers through Tickeron’s AI Trend Prediction Engine highlights the improving momentum in deliveries.

Market Reaction and Investor Sentiment

BA shares have declined roughly 4% year-to-date and approximately 11% over the trailing twelve months, reflecting lingering caution around the pace of the financial turnaround. However, sentiment heading into the Q2 report appears cautiously optimistic. The stock carries a consensus Buy rating among analysts, with an average price target near $277, implying meaningful upside from current levels.

The options market is pricing in a post-earnings swing of about 6%, exceeding Boeing's recent average post-earnings move of just under 4%. This elevated implied volatility suggests traders are bracing for a larger-than-usual reaction, reflecting both the significance of the delivery ramp and uncertainty around free cash flow and potential defense segment charges. Boeing has beaten EPS estimates in two of the last four quarters, including a 70% surprise to the upside in Q1 2026, adding to the sense that expectations may still be conservative relative to improving operational momentum.

Forward Outlook and Key Factors to Monitor

Looking beyond the Q2 print, several interconnected factors will shape Boeing's trajectory through the remainder of 2026 and into 2027.

Production ramp execution remains the central narrative. The 737 program's move to 47 aircraft per month is a critical operational milestone that directly influences Boeing's ability to convert its enormous backlog into revenue and cash. Any sign that the rate increase is progressing smoothly — or encountering friction — will carry significant implications for delivery forecasts and financial guidance. The 787 program, which contributed 25 deliveries in Q2, is another closely watched production line.

Free cash flow trajectory is arguably the single most important metric for long-suffering Boeing investors. After burning through cash for multiple years, the company needs to demonstrate that higher deliveries translate into tangible financial improvement. Analysts currently project a near-breakeven fiscal 2026, with profitability expected to return in fiscal 2027. The Q2 report will either reinforce or challenge that timeline.

Cost management and defense segment risks warrant continued attention. Boeing's Defense, Space & Security business has been a recurring source of charges on fixed-price development contracts. While the segment delivered 35 units in Q2, investors will monitor whether program execution is improving or whether additional write-downs loom.

Macro and regulatory considerations also play a role. Tariff policy developments, global trade dynamics, and supply chain stability remain relevant variables. On the regulatory front, potential FAA certification of the 737 MAX 7 and MAX 10 variants could unlock additional delivery opportunities and strengthen Boeing's competitive position against Airbus.

Backlog conversion provides a long-term anchor. Boeing's record $695 billion total backlog, including more than 6,100 commercial airplanes, underscores that demand is not the problem. The investment case hinges entirely on Boeing's ability to produce and deliver aircraft at scale, translating orders into cash and eventually restoring consistent profitability.

Refining Earnings Research with Tickeron Tools

In preparing for reports like this one, I frequently use Tickeron’s AI Screener to quickly filter for stocks showing similar technical setups or fundamental improvements ahead of earnings. It helps narrow down comparable names in the aerospace sector based on patterns, volatility, and AI signals, saving time while highlighting ideas that align with the current delivery trends. This approach has become a regular part of my pre-earnings process.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BA

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


BA's RSI Oscillator ascends from oversold territory

The RSI Oscillator for BA moved out of oversold territory on July 22, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 36 similar instances when the indicator left oversold territory. In of the 36 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 30, 2026. You may want to consider a long position or call options on BA as a result. In of 70 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BA just turned positive on July 28, 2026. Looking at past instances where BA's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

BA moved above its 50-day moving average on August 03, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BA crossed bullishly above the 50-day moving average on August 05, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BA advanced for three days, in of 320 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 257 cases where BA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BA broke above its upper Bollinger Band on August 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (29.851) is normal, around the industry mean (10.177). P/E Ratio (82.853) is within average values for comparable stocks, (65.509). BA's Projected Growth (PEG Ratio) (89.292) is very high in comparison to the industry average of (8.169). Dividend Yield (0.000) settles around the average of (0.016) among similar stocks. P/S Ratio (1.910) is also within normal values, averaging (20.017).

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 43.9B. The market cap for tickers in the group ranges from 4.49 to 1.86T. SPCX holds the highest valuation in this group at 1.86T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was 4%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 6%. DFSC experienced the highest price growth at 88%, while EVTL experienced the biggest fall at -34%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 9%. For the same stocks of the Industry, the average monthly volume growth was 60% and the average quarterly volume growth was 85%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 66
Price Growth Rating: 52
SMR Rating: 78
Profit Risk Rating: 71
Seasonality Score: -28 (-100 ... +100)
View a ticker or compare two or three
BA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of jetliners, aircraft and related products

Industry AerospaceDefense

Profile
Details
Industry
Aerospace And Defense
Address
929 Long Bridge Drive
Phone
+1 703 465-3500
Employees
171000
Web
https://www.boeing.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.